Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Mycophenolate Mofetil Hydrochloride
Therapeutic Area : Ophthalmology
Study Phase : Phase III
Sponsor : Novartis Pharmaceuticals Corporation | University Hospital Tübingen
Deal Size : Inapplicable
Deal Type : Inapplicable
Myfortic for the Treatment of Non-infectious Intermediate Uveitis
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 25, 2010
Lead Product(s) : Mycophenolate Mofetil Hydrochloride
Therapeutic Area : Ophthalmology
Highest Development Status : Phase III
Sponsor : Novartis Pharmaceuticals Corporation | University Hospital Tübingen
Deal Size : Inapplicable
Deal Type : Inapplicable